1'H-Spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one

1'H-Spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one Suppliers list
Company Name: Hubei Co-prosperity Medicine Technonlogy Co., Ltd  Gold
Tel: 2383948258 19172820304
Email: 2383948258@qq.com
Company Name: Pure Chemistry Scientific Inc.  
Tel: 001-857-928-2050 or 1-888-588-9418
Email: sales@chemreagents.com
Company Name: Shanghai Topbiochem Technology Co., Ltd  
Tel: +86-21-60341587
Email: sales@topbiochem.com
Company Name: Chengdu AstaTech Trading Co., Ltd./AstaTech (Chengdu) Pharma. Co., Ltd.  
Tel: +86-28-85122536 85324413
Email: market@astatech.cn
Company Name: Shanghai Kahn Pharmaceutical Co., Ltd.  
Tel: 021-34979681; 17701870669
Email: 41513101@qq.com
1'H-Spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one Basic information
Product Name:1'H-Spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one
Synonyms:1'H-Spiro[piperidine-4,2'-quinazolin]-4'(3'H);1'H-Spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one;Spiro[piperidine-4,2'(1'H)-quinazolin]-4'(3'H)-one
CAS:202826-52-6
MF:C12H15N3O
MW:217.27
EINECS:
Product Categories:
Mol File:202826-52-6.mol
1'H-Spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one Structure
1'H-Spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one Chemical Properties
storage temp. under inert gas (nitrogen or Argon) at 2–8 °C
InChIInChI=1S/C12H15N3O/c16-11-9-3-1-2-4-10(9)14-12(15-11)5-7-13-8-6-12/h1-4,13-14H,5-8H2,(H,15,16)
InChIKeyDMCVIPFZUCHMQV-UHFFFAOYSA-N
SMILESN1CCC2(NC(=O)C3=C(N2)C=CC=C3)CC1
Safety Information
MSDS Information
1'H-Spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one Usage And Synthesis
Synthesis
1-BENZYL-2',3'-DIHYDROSPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-4'(1'H)-ONE

76857-06-2

1'H-Spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one

202826-52-6

A suspension of 1-benzyl-1'H-spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one (5.0 g) was formed with 10% palladium-carbon catalyst (500 mg) in methanol (200 mL). The reaction mixture was stirred at room temperature for 48 hours under hydrogen atmosphere. Upon completion of the reaction, the catalyst was filtered through a diatomaceous earth pad to remove the catalyst. The filtrate was concentrated under reduced pressure to remove the solvent, and the resulting residue was recrystallized using a solvent mixture of ethanol/ether to afford 1H-spiro[piperidin-4,2-quinazolin]-4(3H)-one (2.34 g, 41% yield). The structure of the product was confirmed by 1H NMR (300 MHz, CDCl3): δ 1.81-2.03 (m, 5H), 2.84-2.99 (m, 4H), 4.47 (s, 1H), 6.62-6.85 (m, 2H), 7.24-7.32 (m, 1H), 7.84-7.88 (m, 1H).

References[1] Patent: US2010/69351, 2010, A1. Location in patent: Page/Page column 32
1'H-Spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one Preparation Products And Raw materials
Raw materials1-Benzyl-2',3'-dihydrospiro[piperidine-4,2'-quinazoline]-4'(1'H)-one-->Hydrogen-->Methanol
Tag:1'H-Spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one(202826-52-6) Related Product Information
2'',3''-Dihydro-2''-oxospiro-[piperidine-4,4''(1H'')-quinazoline 1H-Spiro[piperidine-4,2-quinazolin]-4(3H)-one HCl 1-Boc-4'-oxo-3',4'-dihydro-1'H-spiro[piperidine-4,2'-quinazoline] 6'-BroMo-1'H-spiro[piperidine-4,2'-quinazolin]-4'(3'H)-one 7'-Chloro-3',4'-dihydro-1'H-spiro[piperidine-4,2'-quinazoline]-4'-one 6-fluoro-1H-spiro[piperidine-4,2-quinazolin]-4(3H)-one